Vivek Verma

Dr. Vivek Verma

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2016 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
BGBichitra Nandi Ganguly
Bichitra Nandi Ganguly
Vivek VermaVivek Verma
Vivek Verma
Debanuj ChatterjeeDebanuj Chatterjee
Debanuj Chatterjee
BSBiswarup Satpati
Biswarup Satpati
SDSushanta Debnath
Sushanta Debnath
PSPartha Saha
Partha Saha


3 November 2020 in Crystal Growth & Design
Verified
Journal Article
Closed access
RSRodrigo Soto
Rodrigo Soto
Vivek VermaVivek Verma
Vivek Verma
ALAisling Lynch
Aisling Lynch
BHBenjamin K. Hodnett
Benjamin K. Hodnett
ÅRÅke C. Rasmuson
Åke C. Rasmuson

7 March 2019 in CrystEngComm
Verified
Journal Article
Closed access
PDF file
ALAisling Lynch
Aisling Lynch
Vivek VermaVivek Verma
Vivek Verma
JZJacek Zeglinski
Jacek Zeglinski
PBPauric Bannigan
Pauric Bannigan
ÅRÅke Rasmuson
Åke Rasmuson
The effect of solvent on salicylamide's crystal habit was investigated. It is deduced that ethyl acetate is adsorbed more strongly on the faces, the increased size of which, can explain the shape change.

19 September 2018 in Crystal Growth & Design
Verified
Journal Article
Closed access
Vivek VermaVivek Verma
Vivek Verma
JZJacek Zeglinski
Jacek Zeglinski
SHSarah Hudson
Sarah Hudson
PDPeter Davern
Peter Davern
BHBenjamin K. Hodnett
Benjamin K. Hodnett

12 December 2017 in Crystal Growth & Design
Verified
Journal Article
Open access
Vivek VermaVivek Verma
Vivek Verma
RPRaghu Peddapatla
Raghu Peddapatla
CCClare M. Crowley
Clare M. Crowley
ACAbina Crean
Abina Crean
PDPeter Davern
Peter Davern
BHB. Kieran Hodnett
B. Kieran Hodnett
This study is based on the heterogeneous nucleation of active pharmaceutical ingredients (APIs) in the presence of various excipients widely used in the pharmaceutical industry. Carbamazepine (CBMZ) was successfully crystallized in the presence of the following heterosurfaces: α/β-lactose, β-d-mannitol, microcrystalline cellulose, and carboxymethyl cellulose. The successful crystallization of CBMZ FIII in the presence of all the excipients was confirmed by powder X-ray diffraction and scanning electron microscopy, while CBMZ crystals’ apposition was confirmed using in situ scanning electronic microscopy-Raman. A pronounced improvement in the dissolution of CBMZ FIII was observed when crystallized in the presence of excipients when compared with CBMZ FIII recrystallized using the same conditions in the absence of the excipients. The isolated solids could be simply tabletted by direct compression upon mixing with the desired amount of disintegrant and lubricant. Hence employing this process could potentially streamline the downstream process in pharmaceutical industries and also increase the throughput with reduced cost.